CARDIO DIAGNOSTICS HOLDINGS INC
NASDAQ: CDIO (Cardio Diagnostics Holdings Inc)
Last update: 2 hours ago1.85
0.00 (0.00%)
| Previous Close | 1.85 |
| Volume | 14,127 |
| Price / Sales | 328.50 |
| Price / Book | 0.810 |
| 52 Weeks Range |
| Operating Margin (TTM) | -173,463.83% |
| Diluted EPS (TTM) | -4.34 |
| Quarterly Revenue Growth (YOY) | -94.10% |
| Total Debt/Equity (MRQ) | 7.00% |
| Current Ratio (MRQ) | 19.49 |
| Operating Cash Flow (TTM) | -5.16 M |
| Levered Free Cash Flow (TTM) | -3.50 M |
| Return on Assets (TTM) | -43.94% |
| Return on Equity (TTM) | -81.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Cardio Diagnostics Holdings Inc | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 0.5 |
| Average | 0.67 |
|
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 7.55% |
| % Held by Institutions | 4.86% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |